CA2163805A1 - Novel activating factor of leukocytes - Google Patents

Novel activating factor of leukocytes

Info

Publication number
CA2163805A1
CA2163805A1 CA002163805A CA2163805A CA2163805A1 CA 2163805 A1 CA2163805 A1 CA 2163805A1 CA 002163805 A CA002163805 A CA 002163805A CA 2163805 A CA2163805 A CA 2163805A CA 2163805 A1 CA2163805 A1 CA 2163805A1
Authority
CA
Canada
Prior art keywords
sequence
leukocytes
activating factor
novel activating
lect2b
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002163805A
Other languages
French (fr)
Other versions
CA2163805C (en
Inventor
Kazuo Suzuki
Satoshi Yamagoe
Yoshio Yamakawa
Satoshi Mizuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2163805A1 publication Critical patent/CA2163805A1/en
Application granted granted Critical
Publication of CA2163805C publication Critical patent/CA2163805C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Disclosed are human LECT2a polypeptide having amino acid sequence in the order shown in Sequence ID NOs. from 1 to 5 in the sequence table, which did not include other proteins, peptides and human LECT2b polypeptide having amino acid sequence in the order shown in Sequence ID NO. 6 in the same, which did not include other proteins/peptides, and DNA coding LECT2b sequence.
CA002163805A 1994-11-28 1995-11-27 Novel activating factor of leukocytes Expired - Fee Related CA2163805C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP293233/1994 1994-11-28
JP29323394A JP3637087B2 (en) 1994-11-28 1994-11-28 New leukocyte activator

Publications (2)

Publication Number Publication Date
CA2163805A1 true CA2163805A1 (en) 1996-05-29
CA2163805C CA2163805C (en) 2008-07-22

Family

ID=17792158

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002163805A Expired - Fee Related CA2163805C (en) 1994-11-28 1995-11-27 Novel activating factor of leukocytes

Country Status (6)

Country Link
US (1) US5929224A (en)
EP (1) EP0723016B1 (en)
JP (1) JP3637087B2 (en)
AT (1) ATE315646T1 (en)
CA (1) CA2163805C (en)
DE (1) DE69534738T2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3888695B2 (en) 1996-05-27 2007-03-07 株式会社医学生物学研究所 ANTIBODY TO HUMAN LECT2, CELL PRODUCING THE SAME, MEASUREMENT METHOD AND MEASUREMENT KIT
JPH1149698A (en) * 1997-07-31 1999-02-23 Santen Pharmaceut Co Ltd Water-based lactoferrin preparation with increased stability
JP4378439B2 (en) 1998-12-22 2009-12-09 国立感染症研究所長 Bone resorption inhibitor
TW201012473A (en) * 2008-09-22 2010-04-01 Tty Biopharm Co Ltd Composition of inhibiting pathological angiogenesis
CN102559739B (en) * 2012-01-20 2014-06-25 宁波大学 Expressing and purifying method of recombinant human-derived LECT2 protein in Pichia pastoris

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583107A (en) * 1990-09-04 1996-12-10 Cor Therapeutics, Inc. Agents affecting thrombosis and hemostasis
CA2075240A1 (en) * 1991-08-05 1993-02-06 Mitsubishi Chemical Corporation Chondromodulin-ii protein
US5324638A (en) * 1992-05-13 1994-06-28 Sloan-Kettering Institute For Cancer Research Brain transcription factor, nucleic acids encoding same and uses thereof
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
US5532142A (en) * 1993-02-12 1996-07-02 Board Of Regents, The University Of Texas System Method of isolation and purification of fusion polypeptides
US5593877A (en) * 1993-03-11 1997-01-14 The Rockefeller University Nucleic acid and recombinant production of vespid venom hyaluronidase

Also Published As

Publication number Publication date
ATE315646T1 (en) 2006-02-15
EP0723016A2 (en) 1996-07-24
DE69534738D1 (en) 2006-04-06
EP0723016B1 (en) 2006-01-11
EP0723016A3 (en) 1997-08-20
CA2163805C (en) 2008-07-22
JPH08140683A (en) 1996-06-04
DE69534738T2 (en) 2006-08-31
US5929224A (en) 1999-07-27
JP3637087B2 (en) 2005-04-06

Similar Documents

Publication Publication Date Title
CA2263889A1 (en) P-selectin ligand proteins
WO1998055508A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
AUPP051497A0 (en) Antimicrobial peptides
AU7165287A (en) DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
EP1939293A3 (en) Interferon-Like Protein ZCYTO21
GR3030811T3 (en) Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
AU4778101A (en) Novel polypeptides, and nucleic acids encoding the same
CA2111645A1 (en) Fibrinogen fragment e peptides and antibodies thereto
CA2147623A1 (en) Novel p-selectin ligand protein
EP0875567A3 (en) Mycbinding Zinc-finger proteins, preparation and use thereof
CA2249180A1 (en) Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides
GR3033328T3 (en) Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis.
IL87391A0 (en) Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
GB8821785D0 (en) Peptide compounds
WO1995030001A3 (en) Novel p-selectin ligand protein
AU1239997A (en) Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes
CA2163805A1 (en) Novel activating factor of leukocytes
AU6292694A (en) Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
DK0769056T3 (en) Non-splicing variants of gp350 / 220
CA2259640A1 (en) Human glycine transporter
AU8526691A (en) Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
CA2112701A1 (en) Proteins s polypeptides and uses thereof

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed